A comprehensive view of Over-the-Counter (OTC) Products. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Dexcom receives FDA approval for OTC Stelo biosensor wearable glucose monitor that targets people not on insulin and without problematic hypoglycemia; the monitor measures and analyzes glucose levels and reports data via a smartphone app
Published:
March 06, 2024
by San Diego Union-Tribune (CA)
|
Brassica Pharma recalls eye ointment products sold at CVS and Walmart due to potential risk of infection after FDA cites lack of sterility assurance at manufacturing facility; no adverse reports received as of February 16
Published:
March 01, 2024
by WITI-TV (Milwaukee, WI)
|
Intrommune Therapeutics reveals positive data supporting Oral Mucosal Immunotherapy as a potential treatment for food allergies; the findings indicate that specially formulated toothpaste can deliver allergenic proteins
Published:
February 22, 2024
by GlobeNewswire
|
Johns Hopkins Medicine study finds home-use rapid antigen test accurately detects SARS-CoV-2; test compares favorably with clinician-administered test, offering key data on self-testing during the pandemic
Published:
February 13, 2024
by States News Service
|
Hy-Vee partners with Soda Health to launch health and wellness benefits program at all Hy-Vee locations; recipients can receive personalized benefits on fresh produce, over-the-counter pharmacy items, clinical services, nutritional counseling, and more
Published:
January 12, 2024
by Supermarket News
|
Ask us about our Government & Public Policy market view